587 results match your criteria: "Telogen Effluvium"
Introduction: Hair loss can happen for various reasons, including emotional stress, physical strain, certain medical issues, and nutritional gaps. When it comes to nutrition, a lack of vitamin D3 could be linked to diffuse hair loss.
Objectives: The aim was to look for the frequency of vitamin D3 deficiency with diffuse hair fall, especially in the Pakistani population.
Telogen Effluvium Associated With Weight Loss: A Single Center Retrospective Study.
Ann Dermatol
December 2024
Department of Dermatology, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
Background: Telogen effluvium (TE) is characterized by diffuse hair loss following stressful events such as childbirth, prolonged surgery or anesthesia, and severe febrile illnesses, as well as intentional or unintentional rapid weight loss. However, literature regarding the relationship between TE and weight loss is limited.
Objective: To describe the clinical characteristics of TE induced by weight loss and assess their quantitative relationship.
Clinical Features of Patients Treated With Hair Transplants in Female Pattern Hair Loss.
Ann Dermatol
December 2024
Department of Dermatology, College of Medicine, Dankook University, Cheonan, Korea.
Background: Hair transplantation (HT) has been reported to be effective for the treatment of female-pattern hair loss (FPHL). Few studies have investigated HT in FPHL.
Objective: To evaluate the clinical features of FPHL treated with HT and analyze the real-world results of HT.
A Well-Tolerated Hair Serum Containing New Natural Active Ingredients Reduced Hair Loss and Improved Quality of Life in Women With Chronic Telogen Effluvium: A 16-Week Controlled Study.
J Cosmet Dermatol
December 2024
Centre de Santé Sabouraud, Hôpital Saint-Louis, Paris, France.
Background: Chronic telogen effluvium (CTE) is characterized by hair loss lasting for more than 6 months and severely impairs quality of life (QoL). There is no specific treatment.
Aims: To assess the dermatological tolerance and clinical efficacy of a hair serum containing three plant-derived active ingredients (a Silybum marianum extract, Manganese PCA, and a Lespedeza capitata extract) in women with CTE.
Global epidemiology of telogen effluvium after the COVID-19 pandemic: A systematic review and modeling study.
JAAD Int
February 2025
Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
Telogen Effluvium Following the Treatment of Euglycemic Diabetic Ketoacidosis in a Patient With Heavy Soft Drink Intake: A Case Report.
Cureus
October 2024
Internal Medicine, Saitama Citizens Medical Center, Saitama, JPN.
Telogen effluvium can be triggered by physical exhaustion, drug use, and emotional stress. However, in approximately 33% of cases, the triggers are unknown. Telogen effluvium can develop two to three months after exposure to triggers and improve three to six months after trigger removal.
View Article and Find Full Text PDFEfficacy and Safety of Laser Therapy and Phototherapy in Cicatricial and NonCicatricial Alopecia: A Systematic Review Study.
Health Sci Rep
November 2024
Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine Iran University of Medical Sciences (IUMS) Tehran Iran.
Background And Aims: In recent years, the application of various light and laser devices in the treatment of different types of alopecia has been established. This systematic review aims to assess the efficacy and safety of laser therapy and phototherapy in cicatricial and non-cicatricial alopecia.
Methods: A comprehensive search was conducted on PubMed, Scopus, Science Direct, and Google Scholar.
Knowledge, attitude, and practice of primary health physicians in Saudi Arabia in prescribing vitamins and minerals as treatment for hair loss.
J Family Med Prim Care
September 2024
Public Health Department, King Fahad Specialist Hospital, Buraydah, Saudi Arabia.
Article Synopsis
- * Data was collected through an online questionnaire from 146 physicians, revealing that while nearly 54% were junior practitioners, both junior and senior physicians had low mean scores for knowledge (12.6) and practice (8) concerning hair loss treatment.
- * The authors conclude that there is a need for improved guidelines to enhance physician knowledge and practice about hair loss, recommending that future research look at the concerns of different experience levels separately.
Postpartum hair loss is associated with anxiety.
J Obstet Gynaecol Res
December 2024
Department of Obstetrics and Gynecology, Institute of Science Tokyo, Tokyo, Japan.
Aim: This study examined the relationship between postpartum hair loss and psychological symptoms.
Methods: This questionnaire-based, cross-sectional study included postpartum women who had delivered at two facilities and completed the questionnaire 10-18 months after delivery. Study protocols were sent by mail in two parts.
The Proportion of Catagen and Telogen Hair Follicles in Occipital Scalp of Male Androgenetic Alopecia Patients: Challenging the Established Dogma.
Exp Dermatol
October 2024
Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
Article Synopsis
- Hair follicles undergo a continuous cycle of growth (anagen), regression (catagen), and rest (telogen), with the time spent in each phase affecting hair length and health.
- Traditional beliefs suggest that 85%-90% of hair follicles are in the growth phase, but recent studies indicate that these values may not be accurate due to flaws in assessment methods.
- A new examination of hair follicles during hair transplants revealed that catagen follicles (7.5%) are more prevalent than previously thought, challenging the established belief about the distribution of hair follicles in different stages.
Vitamin D deficiency in non-scarring and scarring alopecias: a systematic review and meta-analysis.
Front Nutr
October 2024
Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Background: Numerous studies have linked vitamin D deficiency (VDD) to the pathogenesis of various alopecia disorders.
Objective: This study aimed to investigate whether patients with alopecia are more likely to have VDD or lower vitamin D levels than controls, and the prevalence of VDD among patients with certain alopecia disorders.
Methods: Electronic searches were conducted using PubMed, Embase, Scopus, and Cochrane Library databases from the dates of their inception until September 2024.
Low-Level Laser and LED Therapy in Alopecia: A Systematic Review and Meta-Analysis.
Dermatol Surg
October 2024
All authors are affiliated with the Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
Article Synopsis
- Low-level laser/LED therapy (LLLT) might help treat various types of alopecia, but there's a lack of comprehensive reviews on its effectiveness across different types.* -
- A systematic review examined 38 studies involving 3,098 patients, finding significant improvements in hair density for those with androgenetic alopecia after undergoing LLLT for 4 to 26 weeks.* -
- While LLLT shows promise for androgenetic alopecia, more research is needed to assess its effectiveness for other types of hair loss.*
Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature.
Ital J Pediatr
September 2024
Pediatrics Department, University Hospital of Foggia, Foggia, Italy.
Article Synopsis
- Multisystem Inflammatory Syndrome in Children (MIS-C) can occur 3-6 weeks after a SARS-CoV2 infection, and vaccinated adolescents show fewer severe cases, but data on younger kids is limited.
- A 6-year-old girl developed MIS-C symptoms one month after receiving her COVID-19 vaccine, despite having no prior detectable infection; diagnosis was confirmed through antibody tests.
- Treatment with immunoglobulins and steroids helped her recover, but she experienced additional complications like pancreatitis and neurological symptoms; follow-up showed no lasting issues, raising questions about the vaccine's role in MIS-C for younger children.
Impact of the COVID-19 pandemic on telogen effluvium: a nationwide multicentre interrupted time series study.
Clin Exp Dermatol
November 2024
Department of Dermatology, Pusan National University School of Medicine, Pusan, Korea.
Article Synopsis
- - The study examines the relationship between telogen effluvium (TE), COVID-19, and COVID-19 vaccinations in patients at dermatology clinics in South Korea.
- - Results showed a significant increase in TE cases after the COVID-19 pandemic, while vaccination appeared to have no impact on TE occurrence.
- - The findings suggest a correlation between the pandemic and TE, but the retrospective design limits the ability to determine causation.
Hair Loss: Diagnosis and Treatment.
Am Fam Physician
September 2024
Boston University Chobanian and Avedisian School of Medicine, Boston, MA.
Article Synopsis
- Over 80 million people in the U.S. experience hair loss, classified mainly as nonscarring alopecias (diffuse, patterned, or focal), with androgenetic alopecia being the most common.
- Treatment options vary: minoxidil is the first line for patterned hair loss, while focal hair loss may require corticosteroids or oral antifungals depending on the cause.
- Hair loss can lead to anxiety, depression, and lower quality of life, emphasizing the importance of patient education on treatment options and realistic expectations.
Dermatology Update on the Challenging Trichodynia.
Actas Dermosifiliogr
September 2024
Hair Disorders Unit, Grupo de Dermatología Pedro Jaén, Madrid, España; Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Departamento de Biología de Sistemas, Facultad de Medicina, Universidad de Alcalá, IRYCIS, Madrid, España.
Article Synopsis
- - Trichodynia is a painful sensation in the scalp often linked to various types of hair loss, including androgenic alopecia and telogen effluvium, and is more common in women with psychiatric issues like anxiety and depression.
- - The exact cause of trichodynia is not well understood, but factors like substance P, inflammation, and mental health conditions may play a role in its development.
- - Currently, there's no specific treatment for trichodynia, but options like botulinum toxin A, antidepressants, and corticosteroids can be explored, prompting a call for more research into effective therapies.
Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation.
Int J Trichology
July 2024
Department of Dermatology and Venereology, Faculty of Medicine, Tanta University, Tanta, Egypt.
Article Synopsis
- Telogen effluvium (TE) is the most common type of hair loss, and Vitamin D may play a key role due to its effects on the immune system and inflammation.
- A study involving 40 women with TE showed significantly lower Vitamin D levels compared to healthy controls, but after 3 months of oral Vitamin D treatment, their levels improved considerably.
- The findings suggest that oral Vitamin D could be beneficial for TE, but more extensive research is needed to determine the appropriate dosages and treatment duration.
Dissolvable microneedles loaded ginsenoside Rg3 liposome: a transdermal delivery approach for alopecia treatment.
Regen Biomater
July 2024
State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Article Synopsis
- The stratum corneum (SC) of the skin prevents effective absorption of topical treatments for alopecia, but microneedles (MNs) can bypass this barrier and deliver drugs directly to the dermis, also stimulating hair growth.
- A new type of microneedle made from hyaluronic acid (HA) and polysaccharide (BSP) encapsulates cholesterol-free ginsenoside Rg3 liposomes, which avoids the negative effects of testosterone on hair regeneration and improves drug absorption.
- In studies on animals, these Rg3-MNs showed effectiveness similar to the popular treatment minoxidil, enhancing hair density and quality while promoting key hair-regeneration genes, indicating potential for treating alopecia. *
Zinc Status in Kurdish Adults With Hair Loss.
Cureus
August 2024
Dermatology, Azadi General Teaching Hospital, Duhok, IRQ.
Article Synopsis
- Zinc is crucial for hair growth and may prevent hair follicle regression, and this study looked into zinc levels among Kurdish adults experiencing hair loss.
- The study involved 200 participants, including 125 with various types of hair loss and 75 healthy controls, measuring their serum zinc levels.
- Results indicated that those with hair loss had significantly lower zinc levels, particularly in the telogen effluvium group, suggesting a strong connection between zinc deficiency and hair loss in this population.
Panax notoginseng saponins loaded W/O microemulsion for alopecia therapy with panthenol as cosurfactant to reduce skin irritation.
Int J Pharm
September 2024
School of Pharmaceutical Sciences, Sun Yat-sen University, University Town, Guangzhou 510006, PR China; State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China; Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, Sun Yat-sen University, University Town, Guangzhou 510006, PR China. Electronic address:
Article Synopsis
- The study highlights the complexity of alopecia treatment and criticizes current therapies for their single-mechanism and long-term side effects.
- A new water-in-oil microemulsion formulation using Panax notoginseng saponins (PNS ME) improves skin penetration and promotes hair growth by enhancing dermal papilla cell mobility and reducing skin irritation.
- PNS ME shows significant therapeutic outcomes for both telogen effluvium and androgenetic alopecia in mice, with promising safety and efficacy compared to traditional treatments like minoxidil.
Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium.
Arch Dermatol Res
August 2024
The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, 240 East 38th Street, 12th Floor, New York, NY, 10016, USA.
Article Synopsis
- Androgenetic alopecia (AGA) affects both the hair and the psychological well-being of patients, with few treatment options available in the past.
- The introduction of low-dose oral minoxidil (LDOM) has changed the game for managing AGA.
- A study found that LDOM works effectively and safely for both patients with AGA alone and those with AGA alongside telogen effluvium, suggesting it can enhance patient outcomes and quality of life.
The Difference Between SARS-CoV-2 Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes.
Dermatol Pract Concept
July 2024
Kutahya Health Science University, Evliya Celebi Training and Research Hospital, Dermatology and Venerology Clinic, Kutahya, Turkey.
Introduction: Telogen effluvium (TE) is a common type of non-cicatricial alopecia, and it is reported frequently in patients with SARS-CoV-2 infection.
Objectives: Herein, we aimed to examine the demographic, dermoscopic, and laboratory features of the patients with SARS-CoV-2 associated TE (CATE) and compare them with TE due to other causes (TEDOC) according to these features.
Methods: In this retrospective case-control study we evaluated the patients who were diagnosed with TE and were above 18 years of age between April and June 2022.
A comprehensive investigation of biochemical status in patients with telogen effluvium: Analysis of Hb, ferritin, vitamin B12, vitamin D, thyroid function tests, zinc, copper, biotin, and selenium levels.
J Cosmet Dermatol
December 2024
Department of Biochemistry, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey.
Article Synopsis
- - The study investigates the nutritional status and levels of certain vitamins and minerals in women with chronic telogen effluvium (TE) compared to a control group, focusing on deficiencies that might contribute to the condition.
- - Results showed that zinc (Zn) levels were significantly lower in TE patients, while selenium (Se) levels were higher; however, no notable differences were found for hemoglobin, ferritin, vitamin B12, thyroid function, vitamin D, copper (Cu), or biotin levels.
- - The Cu/Zn ratio and Se levels emerged as significant indicators for diagnosing chronic telogen effluvium, suggesting a potential link between these nutrient levels and hair loss.
The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies.
Influenza Other Respir Viruses
July 2024
Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Response to Mounessa et al.'s "Commonly prescribed medications associated with alopecia''.
J Am Acad Dermatol
December 2024
Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland; UCD School of Medicine, University College Dublin, Dublin, Ireland; Hair Restoration Blackrock, Dublin, Ireland.